Patient Safety Still the Main Reason for Reporting of Serious Breaches
Recommendation

Thursday, 29 October 2026 9 .00 - 17.15 h
AI/ML-based Methods for Optimizing Pharmaceutical Research Processes
The annual review of MHRA´s GCP referrals has recently been published. In 2019, the MHRA received a total of 112 serious breach notifications, of which patient safety was the main reason for the reporting of serious breaches followed by scientific value and data credibility. This is similar to MHRA´s 2018 report.
In addition, the agency updated the notification form (Serious Breach form) and the associated guidance document.
MHRA´s Common Queries
The MHRA notes that the initial notification of a serious breach must be submitted within 7 days of first awareness. Thus, the agency expects that details and information may be incomplete at that point. However, follow-up reports should provide complete information, including, for example:
- Impact assessment, methodology and outcome,
- Investigation whether the issue happened at other sites / on other trials,
- Root cause assessments and CAPAs,
- Documentation of the issue in the (electronic) Trial Master Files (eTMFs) and in the Clinical Study Reports.
More information can be found on MHRA´s blog "GCP Serious Breaches Update".
Related GMP News
21.10.2026Switzerland: GMP Compliance by Foreign Manufacturers
14.10.2026EU Pharma Package: Council Adopts New Rules
14.10.2026ICH Publishes New Training Material for Quality Guidelines
14.10.2026WHO issues Draft Guidance on Quality Risk Management
26.08.2026GMP and "Planned Deviations" - a Contradiction?
19.08.2026Why Root Cause Analysis is the Key to efficient CAPA


